CDMRP: Duchenne Muscular Dystrophy Research Program - Investigator-Initiated Award, Translational Leverage Award, Therapeutic Idea Award

The Duchenne Muscular Dystrophy Research Award funds the Investigator-Initiated Research Award http://www.grants.gov/web/grants/view-opportunity.html?oppId=277018 

the Translational Leverage Award http://www.grants.gov/web/grants/view-opportunity.html?oppId=277040 

and the Therapeutic Idea Award http://www.grants.gov/web/grants/view-opportunity.html?oppId=277039 

Must address one of these areas:

• Cardiopulmonary studies
• Clinical studies and novel interventions that could improve clinical care and quality of life in the near term, such as:
  • Comorbidity studies
  • Endocrine and bone issues
  • Gastrointestinal issues
  • Cognitive function
  • Discovery and qualification of pharmacodynamic, prognostic, and predictive biomarkers
• Assessment of clinical trial outcomes, such as:
  • Molecular, functional, imaging, etc.
  • Evaluation surrogate markers
  • Evaluating potential composite scores for outcomes assessment
  • Patient-centered outcomes, e.g., quality of life, activities of daily living
• Extension or expansion of preclinical translational data in support of the therapeutic development path (including independent replication and comparative studies)

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=26900